HBsAg clearance in HBeAg negative infection and treated chronic hepatitis B is associated with different HBsAg kinetics

被引：0
|
作者：
Colombatto, P. [1 ]
Bleve, P. [1 ]
Oliveri, F. [1 ]
Cavallone, D. [1 ]
Ricco, G. [1 ,2 ]
Coco, B. [1 ]
Romagnoli, V. [1 ]
Salvati, A. [1 ]
Bonino, F. [3 ]
Brunetto, M. R. [1 ,2 ,3 ]
机构：
[1] Pisa Univ Hosp, Hepatol Unit, Pisa, Italy
[2] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy
[3] Natl Res Council Italy, Biostruct & Bioimaging Inst, Rome, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2020年 / 52卷
关键词：
D O I：
10.1016/j.dld.2019.12.109
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
T-17
引用
收藏
页码：E27 / E28
页数：2
相关论文
共 50 条
  • [21] KINETICS OF HBSAG DECLINE IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B TREATED WITH PEGINTERFERON ALFA-2A ACCORDING TO GENOTYPE AND ITS ASSOCIATION WITH SUSTAINED HBSAG CLEARANCE 4 YEARS POST-TREATMENT
    Brunetto, Mourizia
    Bonino, Ferruccio
    Marcellin, Patrick
    Button, Peter
    Batrla, Richard
    HEPATOLOGY, 2008, 48 (04) : 740A - 740A
  • [22] HBsAg seroconversion: Different kinetics of serum HBsAg level decrease in inactive carriers and chronic hepatitis B patients treated with interferon
    Moucari, Rami
    Mackiewicz, Vincent
    Lada, Olivier
    Devergne, Agnes
    Boyer, Nathalie
    Asselah, Tarik
    Martinot-Peignoux, Michele
    Vidaud, Michel
    Nicolas-Chanoine, Marie-Helene
    Marcellin, Patrick
    HEPATOLOGY, 2007, 46 (04) : 680A - 680A
  • [23] HBSAG LEVELS NEED HBV GENOTYPING TO DIFFERENTIATE INACTIVE CARRIERS HBSAG CARRIERS FROM HBEAG NEGATIVE CHRONIC HEPATITIS B
    Riveiro-Barciela, M.
    Bes, M.
    Homs, M.
    Tabernero, D.
    Casillas, R.
    Sauleda, S.
    Nieto, L.
    Rodriguez-Frias, F.
    Esteban, R.
    Buti, M.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S368 - S369
  • [24] Pretreatment HBsAg serum levels predict HBsAg seroconversion in HBeAg-negative chronic hepatitis B (CHBe-) patients
    Manesis, EK
    Hadziyannis, ES
    Angelopoulou, OP
    Hadziyannis, SJ
    HEPATOLOGY, 2005, 42 (04) : 590A - 590A
  • [25] HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5 years
    Fasano, Massimo
    Lampertico, Pietro
    Marzano, Alfredo
    Di Marco, Vito
    Niro, Grazia Anna
    Brancaccio, Giuseppina
    Marengo, Andrea
    Scotto, Gaetano
    Brunetto, Maurizia Rossana
    Gaeta, Giovanni Battista
    Rizzetto, Mario
    Angarano, Gioacchino
    Santantonio, Teresa
    JOURNAL OF HEPATOLOGY, 2012, 56 (06) : 1254 - 1258
  • [26] ASSOCIATION BETWEEN GENOTYPE AND BASELINE HBsAg LEVELS AND THE HBsAg LEVELS AT HBeAg SEROCLEARANCE IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH ENTECAVIR
    Peng, C. -Y.
    Lai, H. -C.
    Su, W. -P.
    Lin, C. -H.
    Chuang, P. -H.
    Chen, S. -H.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S430 - S430
  • [27] HBsAg loss in HBeAg positive and HBeAg negative patients with chronic HBV treated with Entecavir
    Sungur, Murvet
    Tuzcuoglu, Isil
    Acilar, Kemal
    Gokmen, Tulay
    Kurt, Kamile
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 649 - 649
  • [28] Early Serum HBsAg Kinetics as Predictor of HBsAg Loss in Patients with HBeAg-Negative Chronic Hepatitis B after Treatment with Pegylated Interferonα-2a
    Li, Minghui
    Zhang, Lu
    Lu, Yao
    Chen, Qiqi
    Lu, Huihui
    Sun, Fangfang
    Zeng, Zhan
    Wan, Gang
    Zhao, Linqing
    Xie, Yao
    VIROLOGICA SINICA, 2021, 36 (02) : 311 - 320
  • [29] Early Serum HBsAg Kinetics as Predictor of HBsAg Loss in Patients with HBeAg-Negative Chronic Hepatitis B after Treatment with Pegylated Interferonα-2a
    Minghui Li
    Lu Zhang
    Yao Lu
    Qiqi Chen
    Huihui Lu
    Fangfang Sun
    Zhan Zeng
    Gang Wan
    Linqing Zhao
    Yao Xie
    Virologica Sinica, 2021, 36 (02) : 311 - 320
  • [30] ON-THERAPY HBsAg KINETICS ARE ASSOCIATED WITH HBsAg KINETICS AFTER DISCONTINUATION OF NUCLEOS(T)IDE ANALOGUES (NA) IN NON-CIRRHOTIC HBEAG-NEGATIVE CHRONIC HEPATITIS B (CHBE-)
    Papatheodoridis, George V.
    Hadziyannis, Emilia
    Hadziyannis, Stephanos J.
    HEPATOLOGY, 2019, 70 : 293A - 294A
12345